タナカ　ジユンジ   TANAKA Junji   田中　淳司    所属   その他 その他    職種   非常勤嘱託
論文種別	原著
言語種別	英語
査読の有無	査読あり
表題	Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy.
掲載誌名	正式名：International journal of clinical oncology 略　 称：Int J Clin Oncol ISSNコード：(1437-7772)1341-9625(Linking)
掲載区分	国外
巻・号・頁	22(5),pp.972-979
著者・共著者	Shiseki Masayuki†*, Yoshida Chikashi, Takezako Naoki, Ohwada Akira, Kumagai Takashi, Nishiwaki Kaichi, Horikoshi Akira, Fukuda Tetsuya, Takano Hina, Kouzai Yasuji, Tanaka Junji, Morita Satoshi, Sakamoto Junichi, Sakamaki Hisashi, Inokuchi Koiti
発行年月	2017/10
概要	Switching to dasatinib would be a therapeutic option for CP-CML patients who achieved MMR but not DMR by imatinib, especially for patients who wish to discontinue TKI therapy.
DOI	10.1007/s10147-017-1141-y
PMID	28550414